Skip to content
DataLookout
Menu

RETENTIONNCT07008729

Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 2 months later, primary endpoint(s) modified.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoint(s) modified Show 6 more changesShow less
    • Eligibility criteria expanded, about 17 words
    • Primary completion pushed from Aug 31, 2026 to Oct 31, 2026
    • Study completion pushed from Aug 31, 2026 to Nov 30, 2026
    • Secondary endpoints: 16 to 17
    • Site details revised at 1 of 6 sites
    • Publications: details revised at 12 of 12 entries
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 450 to confirmed 390
    • Site details revised at 6 of 6 sites
    v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Percentage of days lost due to unplanned cardiovascular hospitalization or all-cause death
Timeframe: From randomization through the common 12-month analysis horizon

Secondary (17)

Rates of all-cause mortality
Rates of cardiovascular mortality
Differences in time to first unplanned HF hospitalization
Differences in time to first unplanned cardiovascular hospitalization
Rate of total unplanned HF hospitalizations
Show 12 moreShow less
Rate of total unplanned cardiovascular hospitalizations
Differences in days lost due to HF hospitalizations
Differences in the number of Smart device alarm notifications
Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) score
Change in the levels of NT-proBNP
Change in the Depression Score Patient Health Questionnaire 9 (PHQ-9)
Change in the Heart Failure Caregiver Questionnaire (HF-CQ version 5.0)
Difference in the rate of rejection needing treatment in heart transplant patients
Driveline infection needing antibiotic in left ventricular assist device (LVAD) patients
Differences in the rate of unplanned visit for heart failure requiring intravenous diuretics
Difference in the number of visits outside the protocol
Time to first unplanned cardiovascular hospitalization or all-cause death

Arms and interventions

Intervention groupExperimental

The RETENTION platform will offer to the clinician in the experimental arm all the data gathered by the devices (smart watch, scale, oximeter, blood pressure monitor, temperature, medication adherence, weather and pollution indexes). along with artificial intelligence recommendations.

Control groupPlacebo comparator

Patients in the control group will be monitored but the data will not be available to the clinicians nor the artificial intelligence recommendations.

Devices: Heart monitoring tools (data revision)

Other: Control (Standard treatment)

Sites

6 sites in 4 countries

Greece 2, Spain 2, Germany 1, Italy 1